Xoma Royalty Corporation shares rise 1.98% after-hours following ESSA Pharma's return of capital distribution.

Xoma Royalty Corporation rose 1.98% in after-hours trading, following the announcement by Essa Pharma Inc. regarding its return of capital distribution of US$80,000,000 to shareholders as part of the discontinuance and winding-up of the business. This transaction involves XenoTherapeutics, Inc., a non-profit biotechnology company, acquiring all of Essa Pharma's assets.